The Immune Checkpoint Regulator PD-L1 Is Highly Expressed in Aggressive Primary Prostate Cancer

Heidrun Gevensleben, Dimo Dietrich, Carsten Golletz, +12

Clinical Cancer Research

Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine

Emily Eva Holmes, Maria Jung, Sebastian Meller, +8

PLoS ONE

Bisulfite ConversionEngineeringDna MethylationConversion EfficiencyDna Analysis +18

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition

Dimo Dietrich, Barbara Uhl, Verena Sailer, +4

PLoS ONE

Paraffin-embedded TissuesDna AnalysisMolecular BiologyNucleic Acid Amplification TestBiomedical Engineering +16

A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer

Edward S. Kim, Charles Lu, Fadlo R. Khuri, +6

Lung Cancer

MedicinePathologyPhase Ii StudyBronchial NeoplasmCancer Treatment +4

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions

Dimo Dietrich, Maria Jung, Svenja Puetzer, +7

PLoS ONE

Molecular Diagnostic TechniquesPleural EffusionsCancer DetectionMedicineSept9 Dna Methylation +12

Outwitting EF-Tu and the ribosome: translation with d-amino acids

John Achenbach, Michael Jahnz, Lucas Bethge, +6

Nucleic Acids Research

A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma.

Alexander N. Shoushtari, Ragini R. Kudchadkar, Katherine S. Panageas, +13

Journal of Clinical Oncology

Tumor BiologyRandomized Phase 2MedicineMelanomaAdvanced Um +9

TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomy

Kasper Drimer Berg, Davide Soldini, Maria Jung, +6

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Prognostic BiomarkersUrologyTrpm4 Protein ExpressionMedicineBiomarker Target +6

PITX2 DNA Methylation as Biomarker for Individualized Risk Assessment of Prostate Cancer in Core Biopsies

Barbara Uhl, Heidrun Gevensleben, Yuri Tolkach, +8

Journal of Molecular Diagnostics

Biomarker (Medicine)UrologyMedicinePathologyPitx2 Dna Methylation +6

Phase 2 trial of mifepristone (RU‐486) in advanced or recurrent endometrioid adenocarcinoma or low‐grade endometrial stromal sarcoma

Lois M. Ramondetta, Alaina J. Johnson, Charlotte C. Sun, +6

Cancer